ArticleJCO precision oncology2022

Real-World Data From a Molecular Tumor Board: Improved Outcomes in Breast and Gynecologic Cancers Patients With Precision Medicine.

Lindsey M Charo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.